Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/119310
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSchlicht, Jonas M. A.-
dc.contributor.authorAhlrep, Undine-
dc.contributor.authorHofmann, Britt-
dc.contributor.authorKirchhefer, Uwe-
dc.contributor.authorNeumann, Joachim-
dc.contributor.authorGergs, Ulrich-
dc.date.accessioned2025-06-25T10:52:50Z-
dc.date.available2025-06-25T10:52:50Z-
dc.date.issued2025-
dc.identifier.urihttps://opendata.uni-halle.de//handle/1981185920/121268-
dc.identifier.urihttp://dx.doi.org/10.25673/119310-
dc.description.abstractClozapine is an atypical antipsychotic (neuroleptic) drug. Clozapine binds to H2-histamine receptors in vitro. We wanted to test the hypothesis that clozapine might be a functional antagonist at human cardiac H2-histamine receptors. To that end, we studied isolated electrically stimulated left atrial preparations and spontaneously beating right atrial preparations from transgenic mice with cardiomyocyte-specific overexpression of the human H2-histamine receptor (H2-TG). For comparison, we used wild-type littermate mice (WT). Finally, we measured isometric force of contraction in isolated electrically stimulated muscle strips from the human right atrium (HAP) obtained from patients during bypass surgery. After pre-stimulation with histamine, clozapine (up to 10 µM) concentration and time dependently decreased beating rate in right atrial preparations from H2-TG. Clozapine concentration dependently 1, 3, and 10 µM decreased histamine-stimulated force of contraction in HAP. Clozapine (10 µM) decreased also the isoprenaline-stimulated force of contraction in HAP. In summary, clozapine can antagonize the function of H2-histamine and β-receptors in the human heart.eng
dc.language.isoeng-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subject.ddc610-
dc.titleClozapine is a functional antagonist at cardiac human H2-histamine receptorseng
dc.typeArticle-
local.versionTypepublishedVersion-
local.bibliographicCitation.journaltitleNaunyn-Schmiedeberg's archives of pharmacology-
local.bibliographicCitation.volume398-
local.bibliographicCitation.issue6-
local.bibliographicCitation.pagestart6691-
local.bibliographicCitation.pageend6706-
local.bibliographicCitation.publishernameSpringer-
local.bibliographicCitation.publisherplaceBerlin-
local.bibliographicCitation.doi10.1007/s00210-024-03683-7-
local.openaccesstrue-
dc.identifier.ppn1915126770-
cbs.publication.displayform2025-
local.bibliographicCitation.year2025-
cbs.sru.importDate2025-06-25T10:52:04Z-
local.bibliographicCitationEnthalten in Naunyn-Schmiedeberg's archives of pharmacology - Berlin : Springer, 1873-
local.accessrights.dnbfree-
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
s00210-024-03683-7.pdf2.39 MBAdobe PDFThumbnail
View/Open